Skip to main content

Silexion Therapeutics Corp 8-K, filed Nov 19, 2026

Silexion Therapeutics Corp (SLXN)

8-K 2026-11-19 For: 2026-11-19
View Original
Added on November 19, 2026

About this 8-K

Silexion Therapeutics Corp filed this 8-K on November 19, 2026.

A Nasdaq Hearings Panel granted Silexion continued listing, subject to conditions. The company must complete a $2.5 million private placement by December 4, 2026, and a public offering of at least $5 million by March 31, 2027. AI summary

Items reported

  • Item 8.01: Other events